239 related articles for article (PubMed ID: 20155998)
1. Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder.
Croxtall JD; Scott LJ
CNS Drugs; 2010 Mar; 24(3):245-62. PubMed ID: 20155998
[TBL] [Abstract][Full Text] [Related]
2. Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression.
Deeks ED; Keating GM
Drugs; 2008; 68(8):1115-37. PubMed ID: 18484802
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
Shelton RC; Williamson DJ; Corya SA; Sanger TM; Van Campen LE; Case M; Briggs SD; Tollefson GD
J Clin Psychiatry; 2005 Oct; 66(10):1289-97. PubMed ID: 16259543
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
Thase ME; Corya SA; Osuntokun O; Case M; Henley DB; Sanger TM; Watson SB; Dubé S
J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on olanzapine/fluoxetine in acute bipolar depression.
Deeks ED; Keating GM
CNS Drugs; 2008; 22(9):793-5. PubMed ID: 18698877
[TBL] [Abstract][Full Text] [Related]
7. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
Amsterdam JD; Shults J
J Affect Disord; 2005 Jul; 87(1):121-30. PubMed ID: 15923042
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.
Owen RT
Drugs Today (Barc); 2006 Mar; 42(3):185-92. PubMed ID: 16628260
[TBL] [Abstract][Full Text] [Related]
9. The combination of olanzapine and fluoxetine in mood disorders.
Shelton RC
Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
[TBL] [Abstract][Full Text] [Related]
10. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
Andersen SW; Clemow DB; Corya SA
J Clin Psychiatry; 2005 Nov; 66(11):1468-76. PubMed ID: 16420086
[TBL] [Abstract][Full Text] [Related]
11. Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study.
Corey-Lisle PK; Birnbaum H; Greenberg P; Marynchenko M; Dube S
Psychopharmacol Bull; 2003; 37(3):90-8. PubMed ID: 14608242
[TBL] [Abstract][Full Text] [Related]
12. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF
J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
[TBL] [Abstract][Full Text] [Related]
13. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.
Bobo WV; Shelton RC
Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine/Fluoxetine (Symbyax) for bipolar depression.
Med Lett Drugs Ther; 2004 Mar; 46(1178):23-4. PubMed ID: 15037858
[No Abstract] [Full Text] [Related]
16. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
Zanarini MC; Frankenburg FR; Parachini EA
J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
Tohen M; Case M; Trivedi MH; Thase ME; Burke SJ; Durell TM
J Clin Psychiatry; 2010 Apr; 71(4):451-62. PubMed ID: 20361905
[TBL] [Abstract][Full Text] [Related]
18. A novel augmentation strategy for treating resistant major depression.
Shelton RC; Tollefson GD; Tohen M; Stahl S; Gannon KS; Jacobs TG; Buras WR; Bymaster FP; Zhang W; Spencer KA; Feldman PD; Meltzer HY
Am J Psychiatry; 2001 Jan; 158(1):131-4. PubMed ID: 11136647
[TBL] [Abstract][Full Text] [Related]
19. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]